Practical Management of Antibiotic Hypersensitivity in 2017

Eric Macy, Antonino Romano, David Khan

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Antibiotics are the most common class of medications that individuals report allergy or intolerance to. Adverse reactions are reported at a predictable rate with all antibiotic use that vary by antibiotic. Antibiotic allergy incidence rates are sex dependent, higher in females than in males. Most of these events are not reproducible or immunologically mediated. Antibiotic allergy prevalence increases with increasing age and is more common in hospitalized populations and in populations that use more antibiotics. Determining potential mechanisms for the observed symptoms of the adverse reactions is the starting point for effective management of antibiotic hypersensitivity. Skin testing and direct challenges are the primary tools used to determine acute tolerance in 2017. Commercially available in vitro testing is not currently clinically useful in determining antibiotic hypersensitivity, with rare exceptions. Desensitization can be used when acute-onset immunologically mediated hypersensitivity is confirmed to safely administer a needed antibiotic. Desensitization is not possible when clinically significant T-cell-mediated delayed-type hypersensitivity is present. Effective management of antibiotic allergy is an important part of a comprehensive antibiotic stewardship program.

Original languageEnglish (US)
JournalJournal of Allergy and Clinical Immunology: In Practice
DOIs
StateAccepted/In press - Oct 31 2016

Fingerprint

Hypersensitivity
Anti-Bacterial Agents
Delayed Hypersensitivity
Population
T-Lymphocytes
Skin
Incidence

Keywords

  • Allergy
  • Antibiotic
  • Challenge
  • Desensitization
  • Hypersensitivity
  • Intolerance
  • Management
  • Skin test

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Practical Management of Antibiotic Hypersensitivity in 2017. / Macy, Eric; Romano, Antonino; Khan, David.

In: Journal of Allergy and Clinical Immunology: In Practice, 31.10.2016.

Research output: Contribution to journalArticle

@article{0716da0efbc24034826107707db563a8,
title = "Practical Management of Antibiotic Hypersensitivity in 2017",
abstract = "Antibiotics are the most common class of medications that individuals report allergy or intolerance to. Adverse reactions are reported at a predictable rate with all antibiotic use that vary by antibiotic. Antibiotic allergy incidence rates are sex dependent, higher in females than in males. Most of these events are not reproducible or immunologically mediated. Antibiotic allergy prevalence increases with increasing age and is more common in hospitalized populations and in populations that use more antibiotics. Determining potential mechanisms for the observed symptoms of the adverse reactions is the starting point for effective management of antibiotic hypersensitivity. Skin testing and direct challenges are the primary tools used to determine acute tolerance in 2017. Commercially available in vitro testing is not currently clinically useful in determining antibiotic hypersensitivity, with rare exceptions. Desensitization can be used when acute-onset immunologically mediated hypersensitivity is confirmed to safely administer a needed antibiotic. Desensitization is not possible when clinically significant T-cell-mediated delayed-type hypersensitivity is present. Effective management of antibiotic allergy is an important part of a comprehensive antibiotic stewardship program.",
keywords = "Allergy, Antibiotic, Challenge, Desensitization, Hypersensitivity, Intolerance, Management, Skin test",
author = "Eric Macy and Antonino Romano and David Khan",
year = "2016",
month = "10",
day = "31",
doi = "10.1016/j.jaip.2017.02.014",
language = "English (US)",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier",

}

TY - JOUR

T1 - Practical Management of Antibiotic Hypersensitivity in 2017

AU - Macy, Eric

AU - Romano, Antonino

AU - Khan, David

PY - 2016/10/31

Y1 - 2016/10/31

N2 - Antibiotics are the most common class of medications that individuals report allergy or intolerance to. Adverse reactions are reported at a predictable rate with all antibiotic use that vary by antibiotic. Antibiotic allergy incidence rates are sex dependent, higher in females than in males. Most of these events are not reproducible or immunologically mediated. Antibiotic allergy prevalence increases with increasing age and is more common in hospitalized populations and in populations that use more antibiotics. Determining potential mechanisms for the observed symptoms of the adverse reactions is the starting point for effective management of antibiotic hypersensitivity. Skin testing and direct challenges are the primary tools used to determine acute tolerance in 2017. Commercially available in vitro testing is not currently clinically useful in determining antibiotic hypersensitivity, with rare exceptions. Desensitization can be used when acute-onset immunologically mediated hypersensitivity is confirmed to safely administer a needed antibiotic. Desensitization is not possible when clinically significant T-cell-mediated delayed-type hypersensitivity is present. Effective management of antibiotic allergy is an important part of a comprehensive antibiotic stewardship program.

AB - Antibiotics are the most common class of medications that individuals report allergy or intolerance to. Adverse reactions are reported at a predictable rate with all antibiotic use that vary by antibiotic. Antibiotic allergy incidence rates are sex dependent, higher in females than in males. Most of these events are not reproducible or immunologically mediated. Antibiotic allergy prevalence increases with increasing age and is more common in hospitalized populations and in populations that use more antibiotics. Determining potential mechanisms for the observed symptoms of the adverse reactions is the starting point for effective management of antibiotic hypersensitivity. Skin testing and direct challenges are the primary tools used to determine acute tolerance in 2017. Commercially available in vitro testing is not currently clinically useful in determining antibiotic hypersensitivity, with rare exceptions. Desensitization can be used when acute-onset immunologically mediated hypersensitivity is confirmed to safely administer a needed antibiotic. Desensitization is not possible when clinically significant T-cell-mediated delayed-type hypersensitivity is present. Effective management of antibiotic allergy is an important part of a comprehensive antibiotic stewardship program.

KW - Allergy

KW - Antibiotic

KW - Challenge

KW - Desensitization

KW - Hypersensitivity

KW - Intolerance

KW - Management

KW - Skin test

UR - http://www.scopus.com/inward/record.url?scp=85016570085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016570085&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2017.02.014

DO - 10.1016/j.jaip.2017.02.014

M3 - Article

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

SN - 2213-2198

ER -